PARP Inhibitors Center Stage for Ovarian Cancer PARP Inhibitors Center Stage for Ovarian Cancer

Dr Susana Banerjee reviews three trials using PARP inhibitors that are likely to change first-line therapy for ovarian cancer.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news